Czech Biotech Brings Next-Generation Diabetes Technology to CTPark Prague North

Prague, 29 October 2026 — CTP, Europe’s largest listed developer, owner, and operator of industrial and logistics properties by gross leasable area (GLA), has signed a lease agreement with Czech biotech company XGLU for 3,000 sqm of space at CTPark Prague North. XGLU will use its new facility to complete development and launch mass production of its next generation of glucose monitoring devices for people with diabetes. The company’s move to CTPark Prague North comes ahead of its planned launch in the EU and developing markets, with a focus on markets where access to regular glycaemic monitoring is a major obstacle to care.

XGLU is developing a compact glucometer that combines several test strips, diagnostic electronics, a battery, and a display in a single device, giving users everything they need to measure their blood sugar without a separate meter or smartphone. Results from a single drop of blood are displayed on the device. A key feature is XGLU’s patented printed display, which contributes to the glucometer’s compact and cost-efficient design.

Designed to be compact, easy to use and affordable, the device aims to simplify regular glucose monitoring for people with diabetes in the European Union and developing markets, particularly where the cost of conventional meters and test strips can be a barrier to regular monitoring.

The new facility will bring XGLU’s development, production, and quality control activities together under one roof. It will include a 250 sqm cleanroom designed to meet ISO 7 standards for biosensor manufacturing, providing the controlled environment required to ensure cleanliness and consistent production processes. The project will further expand the range of development and manufacturing activities at CTPark Prague North.

XGLU combines expertise in electronics, biochemistry, and materials technology and develops its own production equipment. As it prepares to launch mass production, the company is also taking the necessary steps toward obtaining the certifications and regulatory approvals required to bring its products to market. The new facility at CTPark Prague North is a significant milestone in XGLU’s transition from product development to mass production.

CTPark Prague North is a modern and sustainable industrial and technology park strategically located near Prague, with direct access to the D8 motorway to Dresden and the Prague Ring Road. All buildings are BREEAM certified and feature solar panels, rainwater retention systems, and EV charging stations. The park is also home to CTP’s Clubhaus community centre, which includes a café, a healthcare facility, and an amphitheatre. Units ranging from 1,500 sqm to 80,000 sqm provide flexibility for companies of different sizes, from SMEs to large multinational corporations.

 
Giới thiệu về CTP
CTP is Europe’s largest listed developer, owner, and operator of logistics and industrial real estate by gross leasable area (“GLA”), with a portfolio of 14.8 million sqm of GLA in 12 countries and 2.0 million sqm under construction as of June 30, 2026. In the Czech Republic specifically, CTP manages 4.7 million sqm of GLA in more than 60 campuses across the country. The company’s ready-built factories and warehouses, together with its custom-built solutions, serve over 1,700 clients ranging from large blue-chip multinationals to local SMEs. CTP builds long-term partnerships through a client-first approach, maintaining roughly 90% annual retention and generating over 65% of new business from existing client expansion. All new buildings are certified to the BREEAM standard “Very Good” or higher, underscoring the company’s commitment to sustainable development. CTP holds Investment Grade ratings from S&P: BBB (Stable), Moody’s: Baa2 (Stable), and JCR: A (Stable). For more information, visit www.ctp.eu.

Media Contacts:
Šárka Šachl, Giám đốc Tiếp thị, CTP Cộng hòa Séc
Mobil: +420 725 029 012
E-mail: [email protected]

Tashi Erml, Media Representative, Ewing
Mobil: +420 775 106 886
E-mail: [email protected]